Global Health Limited, operating under the Medanta brand, has scheduled its earnings conference call for July 31, 2026, at 2:00 PM IST. The management team will discuss the company’s financial performance for the first quarter of FY27, ended June 30, 2026. This disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The call will be hosted by JM Financial Institutional Securities. Key members of the management team participating in the discussion include Dr. Naresh Trehan, Chairman & Managing Director; Mr. Pankaj Sahni, Group CEO & Director; Mr. Yogesh Kumar Gupta, Chief Financial Officer; and Mr. Gaurav Chugh, Head of Investor Relations.

Stakeholders are advised to register in advance via the provided link to ensure zero wait time. The dial-in number for the universal connection is +91-22-7195 0000. International toll-free numbers have been provided for participants in Singapore, Hong Kong, the USA, and the UK.

Regulatory Compliance

The intimation was signed by Rahul Ranjan, Company Secretary & Compliance Officer of Global Health Limited, on July 24, 2026. The notice was submitted to both the BSE Limited and the National Stock Exchange of India Limited. No financial figures or performance metrics have been disclosed ahead of the scheduled conference call.

Global Health Limited will meet investors and analysts in a series of one-on-one meetings scheduled between June 24 and June 30, 2026. The sessions, organized with Nuvama Institutional Equities, IKIGAI Asset Manager Holdings Private Limited, and Enam Asset Management Company Private Limited, are part of the company's routine investor engagement activities. The company clarified that no unpublished price sensitive information will be disclosed during these interactions.

The meetings provide a platform for the management to discuss the company's operations and performance directly with the investor community. The schedule includes both in-person and virtual sessions across multiple cities.

Meeting Schedule

The intimation was submitted to the exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rahul Ranjan, Company Secretary & Compliance Officer, signed the disclosure on behalf of Global Health Limited. The company noted that the schedule is subject to change in case of any unforeseen circumstances involving the analysts, investors, or the company.